The National Association of Community Health Centers said in an email to its contacts yesterday that Tom Van Coverden, 74, hired by NACHC in 1975 and its leader for decades, has taken leave and been replaced by an interim president
…
Month: January 2022
The 340B Coalition, citing the ongoing COVID-19 pandemic, decided Tuesday to give registrants for its upcoming Jan. 31 to Feb. 2 winter conference in San Diego, Calif., the option of attending in person or remotely via an online portal.
Apexus,
…
Bills have been filed in at least five state legislatures to protect 340B covered entities and their contract pharmacies from discrimination by pharmacy benefit managers (PBMs).
Sixteen states have enacted one or more such laws since 2019, according to
…
The Centers for Medicare & Medicaid Services (CMS) yesterday proposed changing Medicare Part D rules to curb plan sponsors and pharmacy benefit managers’ skyrocketing use of direct and indirect renumeration fees (DIR)—PBMs’ controversial practice of clawing back drug payments to
…
SPONSORED CONTENT
Each year, Visante publishes its list of the top 10 issues facing hospital and health system pharmacy. In 2022, many challenges derive from the pandemic but also present opportunities for leaders to implement new solutions that will drive stronger performance in the future.
- The Pandemic
With a second pandemic winter to deal with, many of the country’s hospitals and other 340B providers need help. Overall, 80+% of hospitals are still struggling with being short-staffed and backlogged from the last wave of COVID-19 as well as challenged financially with increased expenses and decreased revenue. Health centers and other 340B providers have faced many of the same challenges and have played a crucial role in treating our most vulnerable patient populations during this unprecedented time. 340B covered entities are now looking at colder months with a potentially bad influenza season creating a possible “twindemic” situation. Hospitals and other 340B covered entities are looking at a possible “perfect storm” of high demand,
…
More than half (52%) of the $81 billion that U.S. pharmacies and health care providers collected in 2020 in reimbursement from payers for brand-name prescription drugs came through pharmacy and provider participation in the 340B program, up from 14% of
…
New York state and Virginia health centers on Friday asked a federal district judge to deny four insulin and diabetes drug manufacturers’ motion to dismiss the health centers’ antitrust class action over the companies’ denials of 340B pricing when covered
…
A federal judge in Sacramento, Calif., late yesterday declined to stop California Medicaid’s transfer of managed care drug coverage to Medicaid fee for service that took effect on Jan. 1. Health centers enrolled in the 340B drug pricing program pledged
…
Q: Where did you go to college/graduate school?
I graduated Pharmacy school from Oregon State University in 1999. I first graduated with a BS in Chemistry from Southern Oregon
…